EU Approves Zelboraf
February 21, 2012The MRF is delighted to learn that Zelboraf (vemurafenib) has been approved in the European Union for the treatment of adult patients with BRAF V600 mutation-positive metastatic melanoma, the most dangerous form of skin cancer. Tests have shown that Ze …
Mom & Pop’s Selling Cancer
February 14, 2012The recent Congressional report on the way tanning salons market to teenagers is disturbing on a number of levels, though not particularly surprising. This is, after all, just the latest in a long line of stories about misleading and manip …
Fighting Dirty
February 8, 2012I read the report from Congress’ House Energy and Commerce Committee with great interest. They used interns to call 300 tanning salons—at least 3 in each state and the District of Columbia—and asked salon staff questions about t …
Statement from Timothy Turnham, Executive Director Melanoma Research Foundation Regarding House Energy and Commerce Report on Tanning Industry
February 1, 2012For Immediate Release: February 1, 2012 Contact: Berna Diehl Jones Public Affairs (202) 591-4045 [email protected] Statement from Timothy Turnham, Executive Director Melanoma Research Foundation Regarding House Energy and Commerce Report on T …
New Awareness Videos Share the Message about Melanoma
January 13, 2012The Melanoma Research Foundation was excited to learn that members of the Western University of Health Sciences Dermatology Interest Group Association recently created two powerful videos that underscore the seriousness of melanoma. We thank them for t …
Recent Comments